Internal Medicine, Rheumatology · Monterey Park, CA
NPI
1689865503
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
941 S Atlantic Blvd, Suite #101
Monterey Park, CA, 91754
Phone (626) 458-8401
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
23,133 services
Medicare patients, 2024
439
Average age 73
Drug cost, 2024
$4.9M
2,022 prescriptions
Company payments, 2025
$97.91
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramachandran Srinivasan was code J1010 (injection, methylprednisolone acetate, 1 mg), 15,070 times for 176 patients. In total Ramachandran Srinivasan billed 23,133 services in 36 codes, and Medicare paid $186K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 15,070 | 176 | $0.09 | $1,427 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,277 | 137 | $0.08 | $96.18 |
| 96372 Injection Administration | Office | 1,020 | 294 | $10.37 | $11K |
| 36415 Venipuncture Blood Collection | Office | 729 | 320 | $8.64 | $6,302 |
| 20610 Joint Injection | Office | 264 | 146 | $51.54 | $14K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 189 | 72 | $0.42 | $78.7 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 178 | 122 | $3.01 | $535 |
| J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 172 | 81 | $507.66 | $87K |
| 20611 Joint Injection | Office | 147 | 73 | $77.59 | $11K |
| 96415 Chemotherapy Administration | Office | 118 | 23 | $23.43 | $2,765 |
| 96413 Chemotherapy Administration | Office | 109 | 24 | $107.07 | $12K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 108 | 23 | $0.47 | $51.19 |
| 96375 Injection Administration | Office | 107 | 22 | $13.07 | $1,399 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 83 | 19 | $0.01 | $0.71 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 78 | 21 | $0.35 | $27.11 |
By year: 2022 $243K for 9,216 services; 2023 $204K for 8,068 services; 2024 $186K for 23,133 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 729 | 320 | $8.64 | $6,302 |
| 81002 Clinical Chemistry | 20 | 20 | $3.41 | $68.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Ramachandran Srinivasan prescribed most often to Medicare patients was Humira Pen (Adalimumab), with 253 prescriptions and refills. In total Ramachandran Srinivasan wrote 2,022 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Humira Pen Adalimumab | 253 | 253 | 36 | $1.6M |
| Methotrexate Methotrexate Sodium | 242 | 307 | 60 | $2,041 |
| Hydroxychloroquine Sulfate Generic | 229 | 384 | 61 | $5,594 |
| Prednisone Generic | 161 | 181 | 75 | $557 |
| Remicade Infliximab | 152 | 181 | 29 | $849K |
| Evenity (2 Syringes) Romosozumab-Aqqg | 114 | 114 | 30 | $266K |
| Prolia Denosumab | 77 | 462 | 63 | $122K |
| Diclofenac Sodium Generic | 67 | 73 | 31 | $1,136 |
| Actemra Actpen Tocilizumab | 54 | 54 | 12 | $239K |
| Folic Acid Generic | 51 | 96 | 22 | $153 |
| Kevzara Sarilumab | 46 | 46 | 12 | $190K |
| Simponi Golimumab | 43 | 49 | Under 11 | $280K |
| Enbrel Sureclick Etanercept | 38 | 38 | Under 11 | $276K |
| Sulfasalazine Generic | 36 | 52 | Under 11 | $312 |
| Mycophenolate Mofetil Generic | 32 | 50 | 11 | $3,891 |
Brand drugs: 897 claims; generic drugs: 1,125 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramachandran Srinivasan $97.91 ($97.91 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $97.91.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $97.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.